ScripsAmerica Company Executives
| SCRCQ Stock | USD 0.0001 0.00 0.00% |
ScripsAmerica employs about 21 people. The company is managed by 2 executives with a total tenure of roughly 10 years, averaging almost 5.0 years of service per executive, having 10.5 employees per reported executive. Discussion of ScripsAmerica's management performance can provide insight into the enterprise performance.
| Brian Ettinger Chairman Chairman of the Board, CEO |
ScripsAmerica |
ScripsAmerica Management Team Effectiveness
The company has return on total asset (ROA) of (0.5309) % which means that it has lost $0.5309 on every $100 spent on assets. This is way below average. ScripsAmerica's management efficiency ratios could be used to measure how well ScripsAmerica manages its routine affairs as well as how well it operates its assets and liabilities.ScripsAmerica Workforce Comparison
ScripsAmerica is currently regarded as top stock in number of employees category among its peers. The total workforce of Pharmaceutical Retailers industry is at this time estimated at about 219. ScripsAmerica holds roughly 21.0 in number of employees claiming about 10% of equities listed under Pharmaceutical Retailers industry.
The company has Profit Margin (PM) of (0.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09. ScripsAmerica Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ScripsAmerica Price Series Summation is a cross summation of ScripsAmerica price series and its benchmark/peer.
ScripsAmerica Notable Stakeholders
A ScripsAmerica stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ScripsAmerica often face trade-offs trying to please all of them. ScripsAmerica's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ScripsAmerica's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Brian Ettinger | Chairman of the Board, CEO | Profile | |
| Jeffrey CPA | Chief Officer | Profile |
About ScripsAmerica Management Performance
The success or failure of an entity such as ScripsAmerica often depends on how effective the management is. ScripsAmerica management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ScripsAmerica management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ScripsAmerica management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ScripsAmerica, Inc. develops and sells non-sterile topical and transdermal pain creams. On February 8, 2017, the voluntary petition of ScripsAmerica, Inc. for reorganization under Chapter 11 was converted to Chapter 7. Scripsamerica operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 21 people.
ScripsAmerica Workforce Analysis
Traditionally, organizations such as ScripsAmerica use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ScripsAmerica within its industry.ScripsAmerica Manpower Efficiency
Return on ScripsAmerica Manpower
| Revenue Per Employee | 1.5M | |
| Revenue Per Executive | 15.4M | |
| Net Loss Per Employee | 225.3K | |
| Net Loss Per Executive | 2.4M |
Additional Tools for ScripsAmerica Pink Sheet Analysis
When running ScripsAmerica's price analysis, check to measure ScripsAmerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ScripsAmerica is operating at the current time. Most of ScripsAmerica's value examination focuses on studying past and present price action to predict the probability of ScripsAmerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ScripsAmerica's price. Additionally, you may evaluate how the addition of ScripsAmerica to your portfolios can decrease your overall portfolio volatility.